- Home
- ABEO vs ARL Comparison
ABEO vs ARL Comparison
Compare ABEO & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | ARL |
|---|---|---|
| Founded | 1974 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 268.4M |
| IPO Year | 2005 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ABEO | ARL |
|---|---|---|
| Price | $4.95 | $15.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $18.75 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 3.1K |
| Earning Date | 01-01-0001 | 06-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.74 | ★ 206.59 |
| EPS | ★ 1.35 | 0.97 |
| Revenue | $2,998,000.00 | ★ $50,014,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,589.77 | N/A |
| P/E Ratio | ★ $3.53 | $15.64 |
| Revenue Growth | ★ 258.18 | 5.70 |
| 52 Week Low | $3.93 | $9.43 |
| 52 Week High | $7.54 | $20.00 |
Technical Indicators
Market Signals| Indicator | ABEO | ARL |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 28.22 |
| Support Level | $4.87 | $14.95 |
| Resistance Level | $5.60 | $15.60 |
| Average True Range (ATR) | 0.20 | 0.56 |
| MACD | -0.02 | -0.27 |
| Stochastic Oscillator | 27.73 | 21.92 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.